Breast Cancer Gene-Expression Miner v5.2
(bc-GenExMiner v5.2)

In order to support further development, please cite at least one of the following articles:

Online launch, "Prognostic" module
	bc-GenExMiner: an easy-to-use online platform for gene prognostic analyses in breast cancer. Jézéquel P, Campone M, Gouraud W, Charbonnel C, Leux C, Ricolleau G, Campion L. Breast Cancer Res Treat 2012;131:765-775.
"Correlation" module
	bc-GenExMiner 3.0: new mining module computes breast cancer gene-expression correlation analyses. Jézéquel P, Frénel JS, Campion L, Guérin-Charbonnel C, Gouraud W, Ricolleau G, Campone M. Database (Oxford) 2013;bas060.
"Expression" module
	bc-GenExMiner 4.5: new mining module computes breast cancer differential gene expression analyses. Jézéquel P, Gouraud W, Ben Azzouz F, Guérin-Charbonnel C, Juin P, Lasla H, Campone M. Database (Oxford) 2021;baab007.
TNBC subtyping
	Mesenchymal-like immune-altered is the fourth robust triple-negative breast cancer molecular subtype. Jézéquel P, Lasla H, Gouraud W, Basseville A, Michel B, Frenel J-S, Juin P, Ben Azzouz F, Campone M. Breast Cancer 2024;31:825-840.

Examples:

	Cytoskeleton remodeling induced by SMYD2 methyltransferase drives breast cancer metastasis. Casanova AG, Roth GS, Hausmann S, Lu X, Bischoff LJM, Froeliger EM, Belmudes L, Bourova-Flin E, Flores NM, Morales Benitez A, Chasan T, Caporicci M , Vayr J, Blanchet S, Ielasi F, Rousseaux S, Hainaut P, Gozani O, Le Romancer M, Couté Y, Palencia A, Mazur PK, Reynoird N. Cell Discov 2024;10:12.
	The RasGAP gene, RASAL2, is a tumor and metastasis suppressor. McLaughlin SK, Olsen SN, Dake B, De Raedt T, Lim E, Bronson RT, Beroukhim R, Polyak K, Brown M, Kuperwasser C, Cichowski K. Cancer Cell 2013;24:365-78.
	Reuse of public genome-wide gene expression data. Rung J and Brazma A. Nat Rev Genet 2013;14:89-99.

New Updated on February 7th, 2025.

Citations1,2 During 2025 42 Since 2010 764 1: weekly updated; 2: in peer-reviewed articles